What's Happening?
The Baltimore Orioles are navigating key roster decisions as spring training approaches, including arbitration cases that define the financial structure of their pitching staff. Left-handed reliever Keegan
Akin, a frequently used bullpen arm, lost his arbitration hearing against the Orioles. Akin will earn $2.975 million in 2026, less than the $3.375 million he had filed for. Despite the setback, Akin remains a crucial part of the Orioles' bullpen, having delivered a solid 2025 campaign with a 3.41 ERA over 64 games. His season was impacted by injury, but he returned to contribute as a regular bullpen option. The Orioles aim to maintain experienced relief depth to improve their pitching staff, which has faced scrutiny in recent seasons.
Why It's Important?
The arbitration outcome for Keegan Akin is significant as it provides cost certainty for the Baltimore Orioles, allowing them to allocate resources effectively as they prepare for the upcoming season. For Akin, the decision is a financial disappointment but underscores his role in the team's strategy to enhance bullpen depth. The Orioles' focus on experienced relief pitchers is crucial in the competitive American League East, where strong pitching can be a decisive factor. Akin's ability to improve his strikeout rate while minimizing walks could enhance his value in future arbitration cycles or free agency, impacting his career trajectory and the team's performance.
What's Next?
Looking ahead, Keegan Akin has the opportunity to strengthen his role in the Orioles' bullpen during the 2026 season. If he can build on his strikeout ability and improve command, he may position himself for a larger payday in future arbitration cycles or free agency. The Orioles will continue to refine their roster, potentially making additional moves to bolster their pitching staff. Akin's performance will be closely watched as the team seeks to remain competitive in the challenging American League East.
